ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00.

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...

About Portage Biotech, Inc. Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more ...

NEW YORK (AP) — Tory Burch not only put her own twist on American sportswear in her new fall/winter collection at New York Fashion Week — she made it “twist-ed,” with exaggerated shapes and details, a ...

Spire Wealth Management boosted its position in shares of Avery Dennison Co. (NYSE:AVY – Free Report) by 76.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 301 shares ...

With over 150 curated sessions led by 300 industry experts, VIV Asia 2025 provides an unparalleled platform for knowledge-building and networking.

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.